zolpidem
Vérifier sur tripsit
Zolpidem
Vérifier sur psychonaut
Zolpidem
Vérifier sur isomerdesign
Zolpidem
Vérifier sur druglab
Zolpidem
Vérifier sur drugmap
Zolpidem
Vérifier sur drugmap
Data
InChI: InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3
Synonymes: SR-01000763006-3,DTXSID7045946, ZAFYATHCZYHLPB-UHFFFAOYSA-N,zolpidem,Z-100, NCGC00095179-01, [3H]zolpidem,Sanval,N,N,6-TRIMETHYL-2-P-TOLYL-IMIDAZO(1,2-A)PYRIDINE-3-ACETAMIDE,N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide #,7K383OQI23, Lorex,ambien,CS-1468,BCP10205,UNII-7K383OQI23,N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide.,HY-17441, Zolpidem [INN:BAN],N,N,6-Trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide, Ancer 20,Ancer, Zolpidemum [Latin],AKOS005560130,Zolpidem civ, Specific Substance of Maruyama,Zolpidem, >=98% (HPLC), solid,Zolpidem solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,Zolpidemum,Zolpidem [INN:BAN],CHEMBL911,NCGC00095179-03,STK627113,SL-800750,ZOLPIDEM [VANDF],SL800750, Ambien,NCGC00095179-05,HMS1922F22,DSSTox_GSID_45946,SL 800750; SL-800750; SL800750,SL 80-0750, N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide, Zolpidemum, N,N,6-Trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide,GTPL4362, DEA No 2783,NCGC00095179-02,AB00698471_09,AS-35386,BSPBio_002278,Tox21_111471_1,NCGC00095179-01, UNII-7K383OQI23,BDBM26266,D08690,CAS-82626-48-0,BRD-K44876623-001-01-1,N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide,DB00425,[3H]zolpidem,294Z936,Zolpidem D6,N,N-dimethyl-2-[(4S)-6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide,Zolpidemum [Latin],82626-48-0,Sanval (TN),SL 800750, N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide,Tox21_111471,ZINC3876, N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide,SR-01000763006,NCGC00095179-04, SL-800750,N,N-Dimethyl-2-[3-methyl-8-(4-methylphenyl)-1,7-diazabicyclo[4.3.0]nona-2,4,6,8-tetraen-9-yl]- acetamide,DTXCID5025946,stilnox,ZOLPIDEM [INN],zolpidem Ambien,ZOLPIDEM [MI],ZOLPIDEM [WHO-DD],BIDD:GT0785, ZolpiMist,6-methyl-N,N-dimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide,Q218842,Zolpidem,GTPL4348,ZOLPIDEM CIV [USP-RS], CHEMBL911,N,N,6-Trimethyl-2-(4-Methyl Phenyl) Imidazo [1,2-alpha] Pyridine-3-Acetamide,DSSTox_CID_25946,SPECTRUM1505369,DSSTox_RID_81244, Zolpidem (low-dose oral spray, middle-of-the-night awakenings),SCHEMBL80516,Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-,C07219,CCG-213403,N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide,N,N-Dimethyl-2-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-acetamide,Zolpidem (INN),CHEBI:10125, 7K383OQI23,N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide, CHEBI:10125, 82626-48-0, SSM, Zolpidem tartrate, Zolpidem (low-dose oral spray, middle-of-the-night awakenings), NovaDel,N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[3,2-a]pyridin-3-yl]acetamide,AB00698471-07
Estimated data
Solubility: -4.349 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 63.2% (prediction based on www.mdpi.com)
